Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
Open Access
- 8 June 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 110 (12), 1646-1660
- https://doi.org/10.1161/circresaha.111.259754
Abstract
Heart disease remains the leading cause of death and disability in the Western world. Current therapies aim at treating the symptoms rather than the subcellular mechanisms, underlying the etiology and pathological remodeling in heart failure. A universal characteristic, contributing to the decreased contractile performance in human and experimental failing hearts, is impaired calcium sequestration into the sarcoplasmic reticulum (SR). SR calcium uptake is mediated by a Ca2+-ATPase (SERCA2), whose activity is reversibly regulated by phospholamban (PLN). Dephosphorylated PLN is an inhibitor of SERCA and phosphorylation of PLN relieves this inhibition. However, the initial simple view of a PLN/SERCA regulatory complex has been modified by our recent identification of SUMO, S100 and the histidine-rich Ca-binding protein as regulators of SERCA activity. In addition, PLN activity is regulated by 2 phosphoproteins, the inhibitor-1 of protein phosphatase 1 and the small heat shock protein 20, which affect the overall SERCA-mediated Ca-transport. This review will highlight the regulatory mechanisms of cardiac contractility by the multimeric SERCA/PLN-ensemble and the potential for new therapeutic avenues targeting this complex by using small molecules and gene transfer methods.Keywords
This publication has 128 references indexed in Scilit:
- The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPaseJournal of Molecular and Cellular Cardiology, 2012
- SUMO1-dependent modulation of SERCA2a in heart failureNature, 2011
- Histidine-rich calcium binding protein: The new regulator of sarcoplasmic reticulum calcium cyclingJournal of Molecular and Cellular Cardiology, 2011
- SERCA2a Gene Transfer Enhances eNOS Expression and Activity in Endothelial CellsMolecular Therapy, 2010
- The anti-apoptotic protein HAX-1 is a regulator of cardiac functionProceedings of the National Academy of Sciences of the United States of America, 2009
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical TrialJournal of Cardiac Failure, 2009
- The Anti-apoptotic Protein HAX-1 Interacts with SERCA2 and Regulates Its Protein Levels to Promote Cell SurvivalMolecular Biology of the Cell, 2009
- Human Mutation in the Anti-apoptotic Heat Shock Protein 20 Abrogates Its Cardioprotective EffectsOnline Journal of Public Health Informatics, 2008
- Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPaseJournal of Molecular and Cellular Cardiology, 2007
- Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteinsJournal of Molecular and Cellular Cardiology, 2007